NLRP1 restricts butyrate producing commensals to exacerbate inflammatory bowel disease

Journal: Nature Communications

Published: 2018-09-13

DOI: 10.1038/s41467-018-06125-0

Affiliations: 24

Authors: 26

Go to article
Institutions FC
Department of Medical Biology, UniMelb, Australia 0.21
Division of Inflammation, WEHI, Australia 0.13
Bio21 Molecular Science and Biotechnology Institute (Bio21 Institute), UniMelb, Australia 0.07
Metabolomics Australia, Australia 0.07
QIMR Berghofer Gut Health Laboratory, Australia 0.05
Division of Bioinformatics, WEHI, Australia 0.05
Department of Food Science and Nutrition, Nara Women's University, Japan 0.04
Department of Clinical Microbiology and Immunology, TAU, Israel 0.04
Department of Microbiology, TCD, Ireland 0.04
QIMR Berghofer Medical Research Institute, Australia 0.04
QIMR Berghofer Medical Genomics Group, Australia 0.04
Yale Department of Immunobiology, United States of America (USA) 0.04
Division of Immunology, WEHI, Australia 0.03
Division of Systems Biology and Personalised Medicine, WEHI, Australia 0.02
Department of Infectious Diseases and Immunology, UU, Netherlands 0.02
Yale University, United States of America (USA) 0.02
Olivia Newton-John Cancer Research Institute (ONJCRI), Australia 0.01
Department of Biochemistry and Molecular Biology, UniMelb, Australia 0.01
ACRF Chemical Biology Division, WEHI, Australia 0.01
Department of Anatomy and Developmental Biology, Monash University, Australia 0.01
Department of Gastroenterology and Hepatology, RBWH, Australia 0.01
School of Medicine (SOM), UQ, Australia 0.01
Sir Peter MacCallum Department of Oncology, UniMelb, Australia 0.01
Bioinformatics and Cancer Genomics Laboratory, Peter Mac, Australia 0.01